Diagnostic and prognostic implications of non-high-density lipoprotein cholesterol and homocysteine levels for cognitive impairment in thalamic infarction

Table 3 Differences in Montreal Cognitive Assessment scores (X ± S)

Group	The number of cases	Visuospatial executive ability	Named	Attention	Language ability	Abstract	Delayed recall	Directional	Total score
The control group	50	3.12 ± 1.04	2.80± 0.45	5.84 ± 0.37	2.88 ± 0.33	1.78 ± 0.51	3.10 ± 1.23	5.86 ± 0.35	25.46 ± 2.41
Cognitively normal group	45	4.39 ± 0.72	2.79 ± 0.39	5.69 ± 0.41	22.98 ± 0.09	1.87 ± 0.15	3.62 ± 0.91	5.63 ± 0.36	26.98 ± 1.20
Cognitive impairment group	35	1.73 ± 1.25	1.62 ± 0.98	12.31 ± 1.09	2.61 ± 0.50	1.43 ± 0.89	2.16 ± 1.01	4.69 ± 1.66	17.13 ± 4.531,2
F/P value	-	11.962/0.000	7.309/0.000	28.304/0.000	329.283/0.000	3.263/0.002	6.784/0.000	341.597/0.000	13.992/0.000

¹P < 0.05 compared with the control group.

²P < 0.05 compared with the group with normal cognitive function.